logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 7
  • 1
    Janmohamed, Jalal
    Born in September 1982
    Individual (4 offsprings)
    Officer
    2005-10-03 ~ now
    OF - Director → CIF 0
    Mr Jalal Janmohamed
    Born in September 1982
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ 2018-09-04
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Janmohamed, Farah
    Born in July 1987
    Individual (4 offsprings)
    Officer
    2017-11-08 ~ now
    OF - Director → CIF 0
  • 3
    Janmohamed, Soraya
    Born in March 1986
    Individual (4 offsprings)
    Officer
    2017-11-08 ~ now
    OF - Director → CIF 0
  • 4
    Khubchandani, Rishi Richie
    Director Business Development born in July 1975
    Individual (1 offspring)
    Officer
    2005-10-03 ~ 2010-03-10
    OF - Director → CIF 0
  • 5
    Janmohamed, Feroze Issa Ismail
    Born in December 1946
    Individual (19 offsprings)
    Officer
    2004-04-05 ~ now
    OF - Director → CIF 0
    Mr Feroze Issa Ismail Janmohamed
    Born in December 1946
    Individual (19 offsprings)
    Person with significant control
    2016-04-06 ~ 2018-09-04
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 6
    Matcham, Debbie
    Individual (2 offsprings)
    Officer
    2004-04-05 ~ now
    OF - Secretary → CIF 0
  • 7
    MEDIPHARMA GROUP LTD 09966815
    Unit 21-22 Mayfield Avenue Industrial Park, Fyfield Road, Weyhill, Andover, England
    Active Corporate (5 parents, 2 offsprings)
    Person with significant control
    2018-09-04 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

WREN LABORATORIES LIMITED

Period: 2005-02-01 ~ now
Company number: 05094520
Registered names
WREN LABORATORIES LIMITED - now
Standard Industrial Classification
32990 - Other Manufacturing N.e.c.
Brief company account
Cost of Sales
-6,091,625 GBP2024-04-01 ~ 2025-03-31
-4,358,225 GBP2023-04-01 ~ 2024-03-31
Distribution Costs
-273,642 GBP2024-04-01 ~ 2025-03-31
-261,079 GBP2023-04-01 ~ 2024-03-31
Administrative Expenses
-5,184,827 GBP2024-04-01 ~ 2025-03-31
-5,309,743 GBP2023-04-01 ~ 2024-03-31
Other Interest Receivable/Similar Income (Finance Income)
675,096 GBP2024-04-01 ~ 2025-03-31
1,627 GBP2023-04-01 ~ 2024-03-31
Interest Payable/Similar Charges (Finance Costs)
-10,209 GBP2024-04-01 ~ 2025-03-31
0 GBP2023-04-01 ~ 2024-03-31
Profit/Loss on Ordinary Activities Before Tax
2,003,307 GBP2024-04-01 ~ 2025-03-31
320,570 GBP2023-04-01 ~ 2024-03-31
Profit/Loss
1,665,807 GBP2024-04-01 ~ 2025-03-31
240,583 GBP2023-04-01 ~ 2024-03-31
Intangible Assets
Other than goodwill
36,827 GBP2025-03-31
12,978 GBP2024-03-31
Property, Plant & Equipment
158,201 GBP2025-03-31
151,274 GBP2024-03-31
Fixed Assets - Investments
952,636 GBP2025-03-31
0 GBP2024-03-31
Fixed Assets
1,147,664 GBP2025-03-31
164,252 GBP2024-03-31
Debtors
2,359,298 GBP2025-03-31
1,795,749 GBP2024-03-31
Cash at bank and in hand
1,050,564 GBP2025-03-31
752,629 GBP2024-03-31
Current Assets
6,530,978 GBP2025-03-31
5,300,766 GBP2024-03-31
Creditors
Amounts falling due within one year
-6,250,268 GBP2025-03-31
-4,202,106 GBP2024-03-31
Net Current Assets/Liabilities
280,710 GBP2025-03-31
1,098,660 GBP2024-03-31
Total Assets Less Current Liabilities
1,428,374 GBP2025-03-31
1,262,912 GBP2024-03-31
Net Assets/Liabilities
1,388,374 GBP2025-03-31
1,222,567 GBP2024-03-31
Equity
Called up share capital
100 GBP2025-03-31
100 GBP2024-03-31
100 GBP2023-03-31
Retained earnings (accumulated losses)
1,388,274 GBP2025-03-31
1,222,467 GBP2024-03-31
3,231,884 GBP2023-03-31
Equity
1,388,374 GBP2025-03-31
1,222,567 GBP2024-03-31
Profit/Loss
Retained earnings (accumulated losses)
1,665,807 GBP2024-04-01 ~ 2025-03-31
240,583 GBP2023-04-01 ~ 2024-03-31
Dividends Paid
Retained earnings (accumulated losses)
-2,250,000 GBP2023-04-01 ~ 2024-03-31
Dividends Paid
-1,500,000 GBP2024-04-01 ~ 2025-03-31
Audit Fees/Expenses
19,748 GBP2024-04-01 ~ 2025-03-31
17,856 GBP2023-04-01 ~ 2024-03-31
Average Number of Employees
1012024-04-01 ~ 2025-03-31
1022023-04-01 ~ 2024-03-31
Wages/Salaries
3,451,103 GBP2024-04-01 ~ 2025-03-31
3,306,017 GBP2023-04-01 ~ 2024-03-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
136,559 GBP2024-04-01 ~ 2025-03-31
133,266 GBP2023-04-01 ~ 2024-03-31
Staff Costs/Employee Benefits Expense
3,998,258 GBP2024-04-01 ~ 2025-03-31
3,821,323 GBP2023-04-01 ~ 2024-03-31
Director Remuneration
48,424 GBP2024-04-01 ~ 2025-03-31
37,634 GBP2023-04-01 ~ 2024-03-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-28,734 GBP2024-04-01 ~ 2025-03-31
34,315 GBP2023-04-01 ~ 2024-03-31
Intangible Assets - Gross Cost
40,606 GBP2025-03-31
15,120 GBP2024-03-31
Intangible Assets - Accumulated Amortisation & Impairment
3,779 GBP2025-03-31
2,142 GBP2024-03-31
Intangible Assets - Increase From Amortisation Charge for Year
1,637 GBP2024-04-01 ~ 2025-03-31
Intangible Assets
36,827 GBP2025-03-31
12,978 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
226,870 GBP2025-03-31
211,798 GBP2024-03-31
Furniture and fittings
6,858 GBP2025-03-31
6,858 GBP2024-03-31
Computers
71,341 GBP2025-03-31
48,846 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
305,069 GBP2025-03-31
267,502 GBP2024-03-31
Property, Plant & Equipment - Other Disposals
Plant and equipment
0 GBP2024-04-01 ~ 2025-03-31
Furniture and fittings
0 GBP2024-04-01 ~ 2025-03-31
Computers
-1,462 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Other Disposals
-1,462 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
92,849 GBP2025-03-31
70,739 GBP2024-03-31
Furniture and fittings
6,858 GBP2025-03-31
6,858 GBP2024-03-31
Computers
47,161 GBP2025-03-31
38,631 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
146,868 GBP2025-03-31
116,228 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
22,110 GBP2024-04-01 ~ 2025-03-31
Furniture and fittings
0 GBP2024-04-01 ~ 2025-03-31
Computers
9,992 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
32,102 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
0 GBP2024-04-01 ~ 2025-03-31
Furniture and fittings
0 GBP2024-04-01 ~ 2025-03-31
Computers
-1,462 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-1,462 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Plant and equipment
134,021 GBP2025-03-31
141,059 GBP2024-03-31
Furniture and fittings
0 GBP2025-03-31
0 GBP2024-03-31
Computers
24,180 GBP2025-03-31
10,215 GBP2024-03-31
Finished Goods/Goods for Resale
2,651,400 GBP2025-03-31
2,421,611 GBP2024-03-31
Trade Debtors/Trade Receivables
Current
2,007,525 GBP2025-03-31
1,495,192 GBP2024-03-31
Amounts Owed by Group Undertakings
Current
9,461 GBP2025-03-31
71,116 GBP2024-03-31
Other Debtors
Current
84,973 GBP2025-03-31
62,982 GBP2024-03-31
Prepayments/Accrued Income
Current
228,950 GBP2025-03-31
166,459 GBP2024-03-31
Trade Creditors/Trade Payables
Current
1,361,620 GBP2025-03-31
726,405 GBP2024-03-31
Amounts owed to group undertakings
Current
3,840,246 GBP2025-03-31
2,698,377 GBP2024-03-31
Corporation Tax Payable
Current
17,664 GBP2025-03-31
114,816 GBP2024-03-31
Other Taxation & Social Security Payable
Current
190,000 GBP2025-03-31
103,349 GBP2024-03-31
Other Creditors
Current
21,860 GBP2025-03-31
72,504 GBP2024-03-31
Accrued Liabilities/Deferred Income
Current
808,669 GBP2025-03-31
486,655 GBP2024-03-31
Creditors
Current
6,250,268 GBP2025-03-31
4,202,106 GBP2024-03-31
Par Value of Share
Class 1 ordinary share
1 GBP2024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2025-03-31
100 shares2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
56,240 GBP2025-03-31
29,167 GBP2024-03-31
Between two and five year
206,213 GBP2025-03-31
0 GBP2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
262,453 GBP2025-03-31
29,167 GBP2024-03-31

Related profiles found in government register
  • WREN LABORATORIES LIMITED
    Info
    WREN DIAGNOSTICS LIMITED - 2005-02-01
    RIDGEWAY DIAGNOSTICS LIMITED - 2005-02-01
    Registered number 05094520
    21 & 22 Mayfield Avenue Industrial Estate Fyfield Road, Weyhill, Andover, Hampshire SP11 8HU
    PRIVATE LIMITED COMPANY incorporated on 2004-04-05 (22 years 1 month). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-04-05
    CIF 0
  • WREN LABORATORIES LIMITED
    S
    Registered number 05094520
    21 & 22 Mayfield Avenue Industrial Park, Fyfield Road, Weyhill, Andover, Hampshire, England, SP11 8HU
    Private Company Limited By Shares in Companies House, United Kingdom
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    MEDIPHARMA LIMITED
    - now 02658133
    EVERRATE LIMITED - 1991-11-14
    21 & 22 Mayfield Avenue Industrial Park, Fyfield Road, Weyhill, Andover, Hampshire
    Active Corporate (13 parents)
    Person with significant control
    2024-04-01 ~ now
    CIF 1 - Ownership of shares – 75% or more OE
    CIF 1 - Right to appoint or remove directors OE
    CIF 1 - Ownership of voting rights - 75% or more OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.